MetLife outlines capital priorities ahead of next earnings, shares in S&P 500 insurance spotlight
22.06.2026 - 16:22:09 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 16:18.
MetLife Inc. (US59156R1086) enters the next reporting stretch with a robust capital framework and a clear focus on shareholder returns. The New York life insurer is part of the S&P 500 and trades on the NYSE under the ticker MET, with analysts highlighting stable earnings power in protection and retirement businesses.
What consensus expects on earnings
For the upcoming first-quarter 2026 report on May 6 after the market close, one detailed preview from Meyka cites consensus expectations of about 2.25 US dollars in earnings per share and roughly 19.5 billion US dollars in revenue for MetLife. The Meyka earnings preview notes that this would reflect solid growth versus the prior-year period, supported by group benefits, Latin America, and asset management.
The same preview reports that MetLife shares recently traded around 78.95 US dollars ahead of that earnings date, implying a market capitalization near 51.5 billion US dollars. According to Meyka’s quantitative assessment, the stock carries a B+ grade, indicating what the provider views as sound fundamentals, fair valuation and manageable leverage for a large life and benefits franchise.
Analyst stance on the MetLife stock
Analyst and market-data aggregators such as MarketBeat show MetLife as a dividend-paying US financial stock with a long operating history, comparing it with peers like Prudential Financial and Manulife in the life and retirement segment. MarketBeat’s MetLife overview points to a broad base of institutional coverage, with the insurer commonly discussed in the context of capital return, rate sensitivity and credit risk.
Commentary around the stock often centers on how management deploys free cash flow between dividends, buybacks and organic growth. For income-focused investors, the cash dividend yield and the stability of underlying earnings streams remain key metrics, while total-return oriented holders also watch book-value development and return-on-equity targets versus other S&P 500 financials.
All news and data on the MetLife shares
Further ad hoc releases, background pieces and real-time price information provide additional context for the MetLife stock beyond today’s consensus snapshot.
How MetLife makes its money
MetLife generates most of its revenue and earnings from life insurance, group disability and dental coverage, retirement and annuity products, and asset-management services for institutional clients. In the United States, its Group Benefits unit offers employer-sponsored life, dental, vision and disability solutions, while Retirement and Income Solutions provides pension risk transfer, structured settlements and institutional annuities to corporate and public-sector clients.
Where the MetLife shares trade today
MetLife shares (US59156R1086) trade on the NYSE at around 85.76 US dollars as of 2026-06-18, 15:59 Eastern, according to recent market data, with a corresponding market capitalization of roughly 52 billion US dollars.
Key data on the MetLife shares
- Company: MetLife Inc.
- ISIN: US59156R1086
- WKN: 938622
- Ticker: MET
- Trading venue: NYSE
- Price (as of 2026-06-18, 15:59): 85.76 USD
- Market cap: 52 billion USD (as of 2026-06-18)
- Sector / industry: Financials / Life & Health Insurance
- Index membership: S&P 500
- Next earnings date: 2026-05-06
Disclaimer: This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer to buy or sell securities. All data are based on sources considered reliable but cannot be guaranteed. Investors should conduct their own research and, where appropriate, consult a qualified financial advisor.
